Eliem Therapeutics Inc
General ticker "ELYM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $170.8M
Eliem Therapeutics Inc follows the US Stock Market performance with the rate: 36.8%.
Estimated limits based on current volatility of 4.3%: low 4.25$, high 4.63$
Factors to consider:
- Earnings expected soon, date: 2024-11-12
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [1.30$, 4.11$]
- 2023-12-31 to 2024-12-30 estimated range: [1.59$, 4.65$]
Short-term ELYM quotes
Long-term ELYM plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $20.93MM | $35.67MM | $45.13MM |
| Operating Income | $-20.93MM | $-35.67MM | $-45.13MM |
| Non-Operating Income | $0.26MM | $-11.81MM | $-0.11MM |
| Interest Expense | $0.00MM | $0.00MM | $1.59MM |
| R&D Expense | $9.34MM | $23.32MM | $26.21MM |
| Income(Loss) | $-20.67MM | $-47.48MM | $-45.24MM |
| Taxes | $-9.16MM | $0.00MM | $0.11MM |
| Profit(Loss) | $-11.51MM | $-47.48MM | $-45.35MM |
| Stockholders Equity | $-24.98MM | $167.20MM | $128.72MM |
| Inventory | $0.00MM | $4.40MM | $0.00MM |
| Assets | $24.63MM | $173.24MM | $134.99MM |
| Operating Cash Flow | $-14.10MM | $-36.07MM | $-37.37MM |
| Investing Cash Flow | $8.08MM | $-114.97MM | $34.44MM |
| Financing Cash Flow | $4.92MM | $177.23MM | $0.00MM |
| Earnings Per Share* | $-0.44 | $-1.81 | $-1.72 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.